Chronic Pancreatitis: Clinical Trials

6 trials for Chronic Pancreatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 21Completed 1

Follow Chronic Pancreatitis: new trials by email Literature Review of Chronic Pancreatitis trials Research Report on Chronic Pancreatitis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pain and Chronic Pancreatitis - Clinical End Experimental Studies
Pregabalin, placebo - Chronic Pancreatitis
Phase 2 / Phase 3CompletedAalborg University Hospital642008-10-012010-08-20
Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis
Triamcinolone, Bupivicaine alone - Chronic Pancreatitis
Phase 3CompletedThe Cleveland Clinic402008-03-012017-06-14
A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)
Placebo, EUR-1008 (APT-1008) High Dose, EUR-1008 (APT-1008) Low Dose - Chronic Pancreatitis, Exocrine Pancreatic Insufficiency
Phase 3CompletedForest Laboratories822008-01-012014-03-12
Safety and Efficacy Study of ViokaseĀ® 16 for the Correction of Steatorrhea
ViokaseĀ® 16, Placebo, Proton pump inhibitor (PPI) - Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Phase 3CompletedForest Laboratories502007-11-012017-03-16
A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy
Pancrelipase delayed release capsule, Placebo Comparator - Chronic Pancreatitis, Pancreatectomy
Phase 3CompletedSolvay Pharmaceuticals522007-10-012011-08-10
Role of Antioxidants Supplementation in Chronic Pancreatitis
Antioxidants, Placebo - Chronic Pancreatitis
Phase 3CompletedAll India Institute of Medical Sciences1272003-10-012009-01-29

Narrower conditions

Pancreatitis, Chronic (6)  ·  Exocrine Pancreatic Insufficiency (3)  ·  Neuralgia (1)  ·  Pain (1)

Broader conditions

Chronic Disease (6)  ·  Digestive System Diseases (6)  ·  Disease Attributes (6)  ·  Pancreatic Diseases (6)  ·  Pancreatitis (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)  ·  Signs and Symptoms (1)

Interventions

Antioxidants (1)  ·  Omeprazole (1)  ·  Pancrelipase (1)  ·  Pregabalin (1)  ·  Proton Pump Inhibitors (1)  ·  Triamcinolone (1)

Sponsors

Forest Laboratories (2)  ·  Aalborg University Hospital (1)  ·  All India Institute of Medical Sciences (1)  ·  Solvay Pharmaceuticals (1)  ·  The Cleveland Clinic (1)

Countries

United States (4)  ·  Poland (2)  ·  Ukraine (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  Denmark (1)  ·  India (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Puerto Rico (1)  ·  Russia (1)  ·  Serbia (1)  ·  Slovakia (1)  ·  South Africa (1)

Top investigators

Payal Bhardwaj, MSc (1)  ·  Pramod K Garg, MD, DM (1)

Results publications

PMID 21848870, PMID 22879908

NIH funding

2004 (1)